Venkat R Chirasani - JoVE Visualize

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Nature Communications|June 7, 2022

Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.

Cancer Letters|February 18, 2021

Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasisYu-Chi Chen, Saketh S Dinavahi, Qilong Feng, et al.

Hypertension (Dallas, Tex. : 1979)|June 22, 2016

Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide PathwayMalapaka Kiranmayi, Venkat R Chirasani, Prasanna K R Allu, et al.

Diabetes|December 4, 2021

Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.

Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Nature Communications|June 7, 2022

Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.

Cancer Letters|February 18, 2021

Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasisYu-Chi Chen, Saketh S Dinavahi, Qilong Feng, et al.

Hypertension (Dallas, Tex. : 1979)|June 22, 2016

Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide PathwayMalapaka Kiranmayi, Venkat R Chirasani, Prasanna K R Allu, et al.

Diabetes|December 4, 2021

Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.

Pageof 5